Veradigm (MDRX) Competitors

Veradigm (NASDAQ:MDRX) and Omnicell (NASDAQ:OMCL) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, community ranking, dividends, institutional ownership, risk and earnings.

Does the MarketBeat Community prefer MDRX or OMCL?

Veradigm received 121 more outperform votes than Omnicell when rated by MarketBeat users. However, 66.75% of users gave Omnicell an outperform vote while only 57.55% of users gave Veradigm an outperform vote.

Company	Underperform	Outperform
Veradigm	Outperform Votes 629 57.55%	Underperform Votes 464 42.45%
Omnicell	Outperform Votes 508 66.75%	Underperform Votes 253 33.25%

Which has more risk & volatility, MDRX or OMCL?

Veradigm has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in MDRX or OMCL?

97.7% of Omnicell shares are held by institutional investors. 2.3% of Veradigm shares are held by insiders. Comparatively, 2.5% of Omnicell shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Is MDRX or OMCL more profitable?

Omnicell has a net margin of 1.13% compared to Veradigm's net margin of 0.00%. Omnicell's return on equity of 3.82% beat Veradigm's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veradigm	N/A	N/A	N/A
Omnicell	1.13%	3.82%	2.07%

Which has better valuation & earnings, MDRX or OMCL?

Omnicell has lower revenue, but higher earnings than Veradigm.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veradigm	$1.53B	0.31	N/A	N/A	N/A
Omnicell	$1.14B	1.23	$12.53M	$0.46	65.09

Do analysts rate MDRX or OMCL?

Veradigm presently has a consensus target price of $13.00, suggesting a potential upside of 195.45%. Omnicell has a consensus target price of $44.83, suggesting a potential upside of 49.74%. Given Veradigm's higher probable upside, equities research analysts plainly believe Veradigm is more favorable than Omnicell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veradigm	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Omnicell	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57

Does the media refer more to MDRX or OMCL?

In the previous week, Omnicell had 1 more articles in the media than Veradigm. MarketBeat recorded 2 mentions for Omnicell and 1 mentions for Veradigm. Veradigm's average media sentiment score of 0.59 beat Omnicell's score of 0.47 indicating that Veradigm is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veradigm	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Omnicell	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Omnicell beats Veradigm on 11 of the 15 factors compared between the two stocks.